NEW YORK, Jan 4, 2026, 17:40 ET — Market closed
UnitedHealth Group (UNH) shares ended Friday up 1.9% at $336.40, closing out the first session of the year with a firm tone in managed care.
The move matters because investors are now lining up around the next big waypoint: UnitedHealth’s full-year results and 2026 outlook. The company said it will report before the market opens on Jan. 27 and host a conference call at 8 a.m. ET.
That guidance will be scrutinized for any sign that medical costs are easing, particularly in Medicare Advantage — privately run plans that manage traditional Medicare benefits — after a bruising stretch for the sector. Traders will also key in on the medical care ratio, which measures medical costs as a share of premiums; a higher ratio typically means tighter underwriting margins.
Health insurers broadly advanced on Friday, with Humana up 3.3% and Elevance Health up 1.1% in a session that also lifted the S&P 500.
UnitedHealth swung between $327.50 and $340.21 during the day and traded roughly 6.9 million shares, in line with its recent daily volumes.
The stock remains volatile on a longer lens. It is still far below its 52-week high of $606.36, with the past-year range running from $234.60 to $606.36, leaving clear technical reference points for traders heading into Monday.
MarketBeat data put the shares above both their 50-day and 200-day moving averages — commonly watched trend lines that smooth out day-to-day swings — while pegging the company’s market value at roughly $305 billion.
On expectations, MarketBeat’s earnings page lists consensus adjusted earnings per share — profit that strips out certain one-off items — at $2.09 for the Jan. 27 report, with expected revenue of about $113.38 billion.
But the path into earnings still runs through policy and compliance risk. UnitedHealth said it would make operational changes after outside audits of parts of its health services and pharmacy-benefit businesses, and it is cooperating with Justice Department investigations into billing practices; CEO Stephen Hemsley wrote that “the work is already well underway.” Reuters
For the broader tape, investors will also watch this week’s U.S. data — including the monthly jobs report due Jan. 9 — for clues on interest-rate expectations that can shift leadership between defensive names like insurers and higher-growth parts of the market.
The next company-specific catalyst is Jan. 27, when UnitedHealth reports results and sets out its 2026 targets — a read-through moment not just for UNH, but for the wider managed-care group.
